Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.45 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Gains from Sales and Divestitures (2024 - 2026)

Updated

Bolt Biotherapeutics (BOLT) reported Gains from Sales and Divestitures of $373,000 for Q2 2026.

Analysis

Bolt Biotherapeutics (BOLT) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bolt Biotherapeutics' Gains from Sales and Divestitures came in at $404,000, up 12.8% year-over-year; for FY2025, it was $288,000, up 311.4% from FY2024.

  • By year, Gains from Sales and Divestitures came in at $70,000 in FY2024 and -$108,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Bolt Biotherapeutics 6.65 Mn 6.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 373,000.00
Mar 31, 2026 31,000.00
Mar 31, 2025 288,000.00
Sep 30, 2024 70,000.00
API Access

Bolt Biotherapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BOLT&period=max&api_key=YOUR_API_KEY